{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:52:56Z","timestamp":1791031976861,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100009907","name":"Grosserer Jakob Ehrenreich og Hustru Grete Ehrenreichs Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009907","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF20OC0065750"],"award-info":[{"award-number":["NNF20OC0065750"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007403","name":"Dagmar Marshalls Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007403","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008276","name":"Skibsreder Per Henriksen, R. og hustrus fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021851","name":"William Demant Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007420","name":"L\u00e6geforeningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007420","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Danmarks Sundhedsfond"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"DOI":"10.1007\/s12028-026-02592-2","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T19:26:36Z","timestamp":1784575596000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glycemic Control in Severe Acute Brain Injury: Systematic Review and Meta-analysis with Trial Sequential Analysis"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6423-4549","authenticated-orcid":false,"given":"Anne-Sophie Worm","family":"Fenger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus Harboe","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene Ravnholt","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe Janum","family":"Eskildsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea Rue","family":"Honor\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Louise","family":"Fabritius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kondziella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe Tellerup","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke","family":"Krogh-Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Gunge","family":"Riberholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"issue":"5","key":"2592_CR1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S2213-2600(14)70061-X","volume":"2","author":"JL Vincent","year":"2014","unstructured":"Vincent JL, Marshall JC, \u00d1amendys-Silva SA, et al. Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit. Lancet Respir Med. 2014;2(5):380\u20136. https:\/\/doi.org\/10.1016\/S2213-2600(14)70061-X.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"2592_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(09)70340-0","volume":"9","author":"CJ van Asch","year":"2010","unstructured":"van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9(2):167\u201376. https:\/\/doi.org\/10.1016\/S1474-4422(09)70340-0.","journal-title":"Lancet Neurol"},{"key":"2592_CR3","doi-asserted-by":"publisher","first-page":"S321","DOI":"10.2337\/dc25-S016","volume":"48","author":"NA ElSayed","year":"2025","unstructured":"ElSayed NA, McCoy RG, Aleppo G, et al. 16. Diabetes care in the hospital: standards of care in diabetes\u20142025. Diabetes Care. 2025;48:S321\u201334. https:\/\/doi.org\/10.2337\/dc25-S016.","journal-title":"Diabetes Care"},{"issue":"9677","key":"2592_CR4","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/S0140-6736(09)60553-5","volume":"373","author":"KM Dungan","year":"2009","unstructured":"Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009;373(9677):1798\u2013807. https:\/\/doi.org\/10.1016\/S0140-6736(09)60553-5.","journal-title":"Lancet"},{"issue":"10","key":"2592_CR5","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1161\/hs1001.096194","volume":"32","author":"SE Capes","year":"2001","unstructured":"Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients. Stroke. 2001;32(10):2426\u201332. https:\/\/doi.org\/10.1161\/hs1001.096194.","journal-title":"Stroke"},{"issue":"12","key":"2592_CR6","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.4065\/78.12.1471","volume":"78","author":"JS Krinsley","year":"2003","unstructured":"Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78(12):1471\u20138. https:\/\/doi.org\/10.4065\/78.12.1471.","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"2592_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/cc6986","volume":"12","author":"PM Vespa","year":"2008","unstructured":"Vespa PM. Intensive glycemic control in traumatic brain injury: what is the ideal glucose range? Crit Care. 2008;12(5):175. https:\/\/doi.org\/10.1186\/cc6986.","journal-title":"Crit Care"},{"issue":"10","key":"2592_CR8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tins.2013.07.001","volume":"36","author":"P Mergenthaler","year":"2013","unstructured":"Mergenthaler P, Lindauer U, Dienel GA, Meisel A. Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends Neurosci. 2013;36(10):587\u201397. https:\/\/doi.org\/10.1016\/j.tins.2013.07.001.","journal-title":"Trends Neurosci"},{"issue":"6","key":"2592_CR9","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1097\/CCM.0b013e3181de562c","volume":"38","author":"J Hermanides","year":"2010","unstructured":"Hermanides J, Bosman RJ, Vriesendorp TM, et al. Hypoglycemia is associated with intensive care unit mortality*. Crit Care Med. 2010;38(6):1430\u20134. https:\/\/doi.org\/10.1097\/CCM.0b013e3181de562c.","journal-title":"Crit Care Med"},{"issue":"12","key":"2592_CR10","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1097\/CCM.0b013e31818f21aa","volume":"36","author":"YM Arabi","year":"2008","unstructured":"Arabi YM, Dabbagh OC, Tamim HM, et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients*. Crit Care Med. 2008;36(12):3190\u20137. https:\/\/doi.org\/10.1097\/CCM.0b013e31818f21aa.","journal-title":"Crit Care Med"},{"issue":"3","key":"2592_CR11","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3945\/ajcn.110.005074","volume":"93","author":"YM Arabi","year":"2011","unstructured":"Arabi YM, Tamim HM, Dhar GS, et al. Permissive underfeeding and intensive insulin therapy in critically ill patients: a randomized controlled trial. Am J Clin Nutr. 2011;93(3):569\u201377. https:\/\/doi.org\/10.3945\/ajcn.110.005074.","journal-title":"Am J Clin Nutr"},{"issue":"3b","key":"2592_CR12","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1590\/S0004-282X2007000500001","volume":"65","author":"JRA de Azevedo","year":"2007","unstructured":"de Azevedo JRA, Lima ERM, Cossetti RJD, de Azevedo RP. Intensive insulin therapy versus conventional glycemic control in patients with acute neurological injury: a prospective controlled trial. Arq Neuropsiquiatr. 2007;65(3b):733\u20138. https:\/\/doi.org\/10.1590\/S0004-282X2007000500001.","journal-title":"Arq Neuropsiquiatr"},{"issue":"Suppl 3","key":"2592_CR13","doi-asserted-by":"publisher","first-page":"P48","DOI":"10.1186\/cc7850","volume":"13","author":"J Azevedo","year":"2009","unstructured":"Azevedo J, Azevedo R, Miranda M, Costa N, Araujo L. Management of hyperglycemia in patients with acute ischemic stroke: comparison of two strategies. Crit Care. 2009;13(Suppl 3):P48. https:\/\/doi.org\/10.1186\/cc7850.","journal-title":"Crit Care"},{"issue":"3","key":"2592_CR14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/ANA.0b013e3180338e69","volume":"19","author":"F Bilotta","year":"2007","unstructured":"Bilotta F, Spinelli A, Giovannini F, Doronzio A, Delfini R, Rosa G. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2007;19(3):156\u201360. https:\/\/doi.org\/10.1097\/ANA.0b013e3180338e69.","journal-title":"J Neurosurg Anesthesiol"},{"issue":"2","key":"2592_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s12028-008-9084-9","volume":"9","author":"F Bilotta","year":"2008","unstructured":"Bilotta F, Caramia R, Cernak I, et al. Intensive insulin therapy after severe traumatic brain injury: a randomized clinical trial. Neurocrit Care. 2008;9(2):159\u201366. https:\/\/doi.org\/10.1007\/s12028-008-9084-9.","journal-title":"Neurocrit Care"},{"issue":"4","key":"2592_CR16","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1097\/TA.0b013e3181c9afc2","volume":"68","author":"A Coester","year":"2010","unstructured":"Coester A, Neumann CR, Schmidt MI. Intensive insulin therapy in severe traumatic brain injury: a randomized trial. J Trauma Injury Infect Crit Care. 2010;68(4):904\u201311. https:\/\/doi.org\/10.1097\/TA.0b013e3181c9afc2.","journal-title":"J Trauma Injury Infect Crit Care"},{"issue":"13","key":"2592_CR17","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","volume":"360","author":"S Finfer","year":"2009","unstructured":"Finfer S, Chittock DR, Su SYS, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283\u201397. https:\/\/doi.org\/10.1056\/NEJMoa0810625.","journal-title":"N Engl J Med"},{"issue":"6","key":"2592_CR18","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00134-015-3757-6","volume":"41","author":"S Finfer","year":"2015","unstructured":"Finfer S, Chittock D, Li Y, et al. Intensive versus conventional glucose control in critically ill patients with traumatic brain injury: long-term follow-up of a subgroup of patients from the NICE-SUGAR study. Intensive Care Med. 2015;41(6):1037\u201347. https:\/\/doi.org\/10.1007\/s00134-015-3757-6.","journal-title":"Intensive Care Med"},{"issue":"3","key":"2592_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12028-010-9417-3","volume":"13","author":"DM Green","year":"2010","unstructured":"Green DM, O\u2019Phelan KH, Bassin SL, Chang CWJ, Stern TS, Asai SM. Intensive versus conventional insulin therapy in critically ill neurologic patients. Neurocrit Care. 2010;13(3):299\u2013306. https:\/\/doi.org\/10.1007\/s12028-010-9417-3.","journal-title":"Neurocrit Care"},{"issue":"13","key":"2592_CR20","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1056\/NEJMoa2304855","volume":"389","author":"J Gunst","year":"2023","unstructured":"Gunst J, Debaveye Y, G\u00fciza F, et al. Tight blood-glucose control without early parenteral nutrition in the ICU. N Engl J Med. 2023;389(13):1180\u201390. https:\/\/doi.org\/10.1056\/NEJMoa2304855.","journal-title":"N Engl J Med"},{"key":"2592_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/00003643-201206001-00365","volume":"29","author":"R Lenhardt","year":"2012","unstructured":"Lenhardt R, Akca O, Biestro A, Bautista A. Strict glycemic control in patients with intracranial hemorrhage, a preliminary report. Eur J Anaesthesiol. 2012;29:112. https:\/\/doi.org\/10.1097\/00003643-201206001-00365.","journal-title":"Eur J Anaesthesiol"},{"issue":"10","key":"2592_CR22","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1007\/s00134-009-1585-2","volume":"35","author":"JC Preiser","year":"2009","unstructured":"Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009;35(10):1738\u201348. https:\/\/doi.org\/10.1007\/s00134-009-1585-2.","journal-title":"Intensive Care Med"},{"issue":"2","key":"2592_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.11.013","volume":"20","author":"J Staszewski","year":"2011","unstructured":"Staszewski J, Brodacki B, Kotowicz J, Stepien A. Intravenous insulin therapy in the maintenance of strict glycemic control in nondiabetic acute stroke patients with mild hyperglycemia. J Stroke Cerebrovasc Dis. 2011;20(2):150\u20134. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2009.11.013.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"19","key":"2592_CR24","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1056\/NEJMoa011300","volume":"345","author":"G Van den Berghe","year":"2001","unstructured":"Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359\u201367. https:\/\/doi.org\/10.1056\/NEJMoa011300.","journal-title":"N Engl J Med"},{"issue":"5","key":"2592_CR25","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1056\/NEJMoa052521","volume":"354","author":"G Van den Berghe","year":"2006","unstructured":"Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449\u201361. https:\/\/doi.org\/10.1056\/NEJMoa052521.","journal-title":"N Engl J Med"},{"issue":"13","key":"2592_CR26","doi-asserted-by":"publisher","first-page":"e6458","DOI":"10.1097\/MD.0000000000006458","volume":"96","author":"Y Wang","year":"2017","unstructured":"Wang Y, Li J, Song Y, Zhao Q. Intensive insulin therapy for preventing postoperative infection in patients with traumatic brain injury. Medicine. 2017;96(13):e6458. https:\/\/doi.org\/10.1097\/MD.0000000000006458.","journal-title":"Medicine"},{"issue":"6","key":"2592_CR27","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.ijnurstu.2009.01.004","volume":"46","author":"M Yang","year":"2009","unstructured":"Yang M, Guo Q, Zhang X, et al. Intensive insulin therapy on infection rate, days in NICU, in-hospital mortality and neurological outcome in severe traumatic brain injury patients: a randomized controlled trial. Int J Nurs Stud. 2009;46(6):753\u20138. https:\/\/doi.org\/10.1016\/j.ijnurstu.2009.01.004.","journal-title":"Int J Nurs Stud"},{"issue":"5","key":"2592_CR28","doi-asserted-by":"publisher","first-page":"R120","DOI":"10.1186\/cc7017","volume":"12","author":"GDC De La Rosa","year":"2008","unstructured":"De La Rosa GDC, Donado JH, Restrepo AH, et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care. 2008;12(5):R120. https:\/\/doi.org\/10.1186\/cc7017.","journal-title":"Crit Care"},{"issue":"11","key":"2592_CR29","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00134-021-06526-8","volume":"47","author":"J Boh\u00e9","year":"2021","unstructured":"Boh\u00e9 J, Abidi H, Brunot V, et al. Individualised versus conventional glucose control in critically-ill patients: the CONTROLING study-a randomized clinical trial. Intensive Care Med. 2021;47(11):1271\u201383. https:\/\/doi.org\/10.1007\/s00134-021-06526-8.","journal-title":"Intensive Care Med"},{"issue":"5","key":"2592_CR30","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1186\/s13054-014-0498-9","volume":"18","author":"R Cinotti","year":"2014","unstructured":"Cinotti R, Ichai C, Orban JC, et al. Effects of tight computerized glucose control on neurological outcome in severely brain injured patients: a multicenter sub-group analysis of the randomized-controlled open-label CGAO-REA study. Crit Care. 2014;18(5):498. https:\/\/doi.org\/10.1186\/s13054-014-0498-9.","journal-title":"Crit Care"},{"issue":"5","key":"2592_CR31","doi-asserted-by":"publisher","first-page":"103045","DOI":"10.1016\/j.dsx.2024.103045","volume":"18","author":"J Meng","year":"2024","unstructured":"Meng J, Li X, Xiao Y, et al. Intensive or liberal glucose control in intensive care units for septic patients? A meta-analysis of randomized controlled trials. Diabetes Metab Syndrome Clin Res Rev. 2024;18(5):103045. https:\/\/doi.org\/10.1016\/j.dsx.2024.103045.","journal-title":"Diabetes Metab Syndrome Clin Res Rev"},{"issue":"5","key":"2592_CR32","doi-asserted-by":"publisher","first-page":"R203","DOI":"10.1186\/cc11812","volume":"16","author":"AH Kramer","year":"2012","unstructured":"Kramer AH, Roberts DJ, Zygun DA. Optimal glycemic control in neurocritical care patients: a systematic review and meta-analysis. Crit Care. 2012;16(5):R203. https:\/\/doi.org\/10.1186\/cc11812.","journal-title":"Crit Care"},{"issue":"2","key":"2592_CR33","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/aas.14166","volume":"67","author":"AW Fenger","year":"2023","unstructured":"Fenger AW, Olsen MH, Fabritius ML, Riberholt CG, M\u00f8ller K. Glycaemic control for patients with severe acute brain injury: protocol for a systematic review. Acta Anaesthesiol Scand. 2023;67(2):240\u20137. https:\/\/doi.org\/10.1111\/aas.14166.","journal-title":"Acta Anaesthesiol Scand"},{"key":"2592_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2020. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"2592_CR35","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (eda). Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane, 2024. Available from www.cochrane.org\/handbook."},{"issue":"9","key":"2592_CR36","doi-asserted-by":"publisher","first-page":"568","DOI":"10.4103\/ijccm.IJCCM_105_17","volume":"21","author":"Y Singh","year":"2017","unstructured":"Singh Y, Nakra M, Verma V, Shankar K, Nachankar A, Kumar KVS. Liraglutide as an alternative to insulin for glycemic control in intensive care unit: a randomized, open-label, clinical study. Indian J Crit Care Med. 2017;21(9):568\u201372. https:\/\/doi.org\/10.4103\/ijccm.IJCCM_105_17.","journal-title":"Indian J Crit Care Med"},{"key":"2592_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019. https:\/\/doi.org\/10.1136\/bmj.l4898.","journal-title":"BMJ"},{"issue":"1","key":"2592_CR38","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1471-2288-14-120","volume":"14","author":"JC Jakobsen","year":"2014","unstructured":"Jakobsen JC, Wetterslev J, Winkel P, Lange T, Gluud C. Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BMC Med Res Methodol. 2014;14(1):120. https:\/\/doi.org\/10.1186\/1471-2288-14-120.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"2592_CR39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1471-2288-9-86","volume":"9","author":"J Wetterslev","year":"2009","unstructured":"Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Med Res Methodol. 2009;9(1):86. https:\/\/doi.org\/10.1186\/1471-2288-9-86.","journal-title":"BMC Med Res Methodol"},{"issue":"7650","key":"2592_CR40","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136. https:\/\/doi.org\/10.1136\/bmj.39489.470347.AD.","journal-title":"BMJ"},{"key":"2592_CR41","unstructured":"McMaster University 2015 (developed by Evidence Prime, Inc.). GRADEpro GDT: GRADEpro Guideline Development Tool [Software]."},{"issue":"5","key":"2592_CR42","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jocn.2011.04.041","volume":"19","author":"T Birnbaum","year":"2012","unstructured":"Birnbaum T, Schmid SP, Feddersen B, Schankin CJ, Straube A. \u201cModerate intensive insulin therapy\u201d is associated with remission of high intracranial pressure in patients with vascular or infectious central nervous system diseases. J Clin Neurosci. 2012;19(5):727\u201332. https:\/\/doi.org\/10.1016\/j.jocn.2011.04.041.","journal-title":"J Clin Neurosci"},{"issue":"3","key":"2592_CR43","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s12028-010-9469-4","volume":"13","author":"C Graffagnino","year":"2010","unstructured":"Graffagnino C, Gurram AR, Kolls B, Olson DM. Intensive insulin therapy in the neurocritical care setting is associated with poor clinical outcomes. Neurocrit Care. 2010;13(3):307\u201312. https:\/\/doi.org\/10.1007\/s12028-010-9469-4.","journal-title":"Neurocrit Care"},{"issue":"5","key":"2592_CR44","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1177\/1479164114530580","volume":"11","author":"YJ Guo","year":"2014","unstructured":"Guo YJ, Zhou Y, Zhang SY, et al. Optimal target range for blood glucose in hyperglycaemic patients in a neurocritical care unit. Diab Vasc Dis Res. 2014;11(5):352\u20138. https:\/\/doi.org\/10.1177\/1479164114530580.","journal-title":"Diab Vasc Dis Res"},{"issue":"4","key":"2592_CR45","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1017\/S0317167100007757","volume":"36","author":"MJ Jacka","year":"2009","unstructured":"Jacka MJ, Torok-Both CJ, Bagshaw SM. Blood glucose control among critically ill patients with brain injury. Can J Neurol Sci. 2009;36(4):436\u201342. https:\/\/doi.org\/10.1017\/S0317167100007757.","journal-title":"Can J Neurol Sci"},{"issue":"5","key":"2592_CR46","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1161\/STROKEAHA.108.535534","volume":"40","author":"JGS Latorre","year":"2009","unstructured":"Latorre JGS, Chou SHY, Nogueira RG, et al. Effective glycemic control with aggressive hyperglycemia management is associated with improved outcome in aneurysmal subarachnoid hemorrhage. Stroke. 2009;40(5):1644\u201352. https:\/\/doi.org\/10.1161\/STROKEAHA.108.535534.","journal-title":"Stroke"},{"key":"2592_CR47","doi-asserted-by":"publisher","first-page":"e10589","DOI":"10.7717\/peerj.10589","volume":"9","author":"P Matovu","year":"2021","unstructured":"Matovu P, Kirya M, Galukande M, et al. Hyperglycemia in severe traumatic brain injury patients and its association with thirty-day mortality: a prospective observational cohort study in Uganda. PeerJ. 2021;9:e10589. https:\/\/doi.org\/10.7717\/peerj.10589.","journal-title":"PeerJ"},{"issue":"4","key":"2592_CR48","doi-asserted-by":"publisher","first-page":"R98","DOI":"10.1186\/cc6974","volume":"12","author":"R Meier","year":"2008","unstructured":"Meier R, B\u00e9chir M, Ludwig S, et al. Differential temporal profile of lowered blood glucose levels (3.5 to 6.5 mmol\/l versus 5 to 8 mmol\/l) in patients with severe traumatic brain injury. Crit Care. 2008;12(4):R98. https:\/\/doi.org\/10.1186\/cc6974.","journal-title":"Crit Care"},{"issue":"1","key":"2592_CR49","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/000313480907500105","volume":"75","author":"A Salim","year":"2009","unstructured":"Salim A, Hadjizacharia P, Dubose J, et al. Persistent hyperglycemia in severe traumatic brain injury: an independent predictor of outcome. Am Surg. 2009;75(1):25\u20139.","journal-title":"Am Surg"},{"issue":"1","key":"2592_CR50","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s12028-009-9222-z","volume":"11","author":"F Schlenk","year":"2009","unstructured":"Schlenk F, Vajkoczy P, Sarrafzadeh A. Inpatient hyperglycemia following aneurysmal subarachnoid hemorrhage: relation to cerebral metabolism and outcome. Neurocrit Care. 2009;11(1):56\u201363. https:\/\/doi.org\/10.1007\/s12028-009-9222-z.","journal-title":"Neurocrit Care"},{"issue":"3","key":"2592_CR51","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/ALN.0b013e318198006a","volume":"110","author":"RH Thiele","year":"2009","unstructured":"Thiele RH, Pouratian N, Zuo Z, et al. Strict glucose control does not affect mortality after aneurysmal subarachnoid hemorrhage. Anesthesiology. 2009;110(3):603\u201310. https:\/\/doi.org\/10.1097\/ALN.0b013e318198006a.","journal-title":"Anesthesiology"},{"issue":"3","key":"2592_CR52","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/ANA.0b013e31821aa6f2","volume":"23","author":"CAM Tiemessen","year":"2011","unstructured":"Tiemessen CAM, Hoedemaekers CWE, van Iersel FM, et al. Intensive insulin therapy increases the risk of hypoglycemia in neurocritical care patients. J Neurosurg Anesthesiol. 2011;23(3):206\u201314. https:\/\/doi.org\/10.1097\/ANA.0b013e31821aa6f2.","journal-title":"J Neurosurg Anesthesiol"},{"issue":"3","key":"2592_CR53","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1097\/01.CCM.0000201875.12245.6F","volume":"34","author":"P Vespa","year":"2006","unstructured":"Vespa P, Boonyaputthikul R, McArthur DL, et al. Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate\/pyruvate ratio after traumatic brain injury*. Crit Care Med. 2006;34(3):850\u20136. https:\/\/doi.org\/10.1097\/01.CCM.0000201875.12245.6F.","journal-title":"Crit Care Med"},{"issue":"3","key":"2592_CR54","first-page":"203","volume":"10","author":"MD Wittenberg","year":"2008","unstructured":"Wittenberg MD, Gattas DJ, Ryan A, Totaro R. Introduction of intensive glycaemic control into a neurosurgical intensive care unit: a retrospective cohort study. Crit Care Resusc. 2008;10(3):203\u20138.","journal-title":"Crit Care Resusc"},{"issue":"4","key":"2592_CR55","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nm.2333","volume":"17","author":"JP Dreier","year":"2011","unstructured":"Dreier JP. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med. 2011;17(4):439\u201347. https:\/\/doi.org\/10.1038\/nm.2333.","journal-title":"Nat Med"},{"issue":"6","key":"2592_CR56","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3171\/jns.1998.89.6.0971","volume":"89","author":"P Vespa","year":"1998","unstructured":"Vespa P, Prins M, Ronne-Engstrom E, et al. Increase in extracellular glutamate caused by reduced cerebral perfusion pressure and seizures after human traumatic brain injury: a microdialysis study. J Neurosurg. 1998;89(6):971\u201382. https:\/\/doi.org\/10.3171\/jns.1998.89.6.0971.","journal-title":"J Neurosurg"},{"issue":"7","key":"2592_CR57","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1097\/01.WCB.0000076701.45782.EF","volume":"23","author":"PM Vespa","year":"2003","unstructured":"Vespa PM, McArthur D, O\u2019Phelan K, et al. Persistently low extracellular glucose correlates with poor outcome 6 months after human traumatic brain injury despite a lack of increased lactate: a microdialysis study. J Cereb Blood Flow Metab. 2003;23(7):865\u201377. https:\/\/doi.org\/10.1097\/01.WCB.0000076701.45782.EF.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"7","key":"2592_CR58","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1097\/01.CCM.0000168054.60538.2B","volume":"33","author":"N Badjatia","year":"2005","unstructured":"Badjatia N, Topcuoglu MA, Buonanno FS, et al. Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage*. Crit Care Med. 2005;33(7):1603\u20139. https:\/\/doi.org\/10.1097\/01.CCM.0000168054.60538.2B.","journal-title":"Crit Care Med"},{"issue":"2","key":"2592_CR59","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s12028-008-9063-1","volume":"9","author":"DA Godoy","year":"2008","unstructured":"Godoy DA, Pi\u00f1ero GR, Svampa S, Papa F, Di Napoli M. Hyperglycemia and short-term outcome in patients with spontaneous intracerebral hemorrhage. Neurocrit Care. 2008;9(2):217\u201329. https:\/\/doi.org\/10.1007\/s12028-008-9063-1.","journal-title":"Neurocrit Care"},{"issue":"3","key":"2592_CR60","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s12028-009-9249-1","volume":"11","author":"DEG Griesdale","year":"2009","unstructured":"Griesdale DEG, Tremblay MH, McEwen J, Chittock DR. Glucose control and mortality in patients with severe traumatic brain injury. Neurocrit Care. 2009;11(3):311\u20136. https:\/\/doi.org\/10.1007\/s12028-009-9249-1.","journal-title":"Neurocrit Care"},{"issue":"3","key":"2592_CR61","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s12028-019-00743-2","volume":"31","author":"T Svedung Wettervik","year":"2019","unstructured":"Svedung Wettervik T, Howells T, Ronne-Engstr\u00f6m E, et al. High arterial glucose is associated with poor pressure autoregulation, high cerebral lactate\/pyruvate ratio and poor outcome following traumatic brain injury. Neurocrit Care. 2019;31(3):526\u201333. https:\/\/doi.org\/10.1007\/s12028-019-00743-2.","journal-title":"Neurocrit Care"},{"issue":"3","key":"2592_CR62","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S1474-4422(07)70055-8","volume":"6","author":"JM Simard","year":"2007","unstructured":"Simard JM, Kent TA, Chen M, Tarasov KV, Gerzanich V. Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol. 2007;6(3):258\u201368. https:\/\/doi.org\/10.1016\/S1474-4422(07)70055-8.","journal-title":"Lancet Neurol"},{"issue":"12","key":"2592_CR63","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.3390\/nu12123906","volume":"12","author":"C Watt","year":"2020","unstructured":"Watt C, Sanchez-Rangel E, Hwang JJ. Glycemic variability and CNS inflammation: reviewing the connection. Nutrients. 2020;12(12):3906. https:\/\/doi.org\/10.3390\/nu12123906.","journal-title":"Nutrients"},{"issue":"1","key":"2592_CR64","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13054-017-1883-y","volume":"22","author":"J Hermanides","year":"2018","unstructured":"Hermanides J, Plummer MP, Finnis M, Deane AM, Coles JP, Menon DK. Glycaemic control targets after traumatic brain injury: a systematic review and meta-analysis. Crit Care. 2018;22(1):11. https:\/\/doi.org\/10.1186\/s13054-017-1883-y.","journal-title":"Crit Care"},{"issue":"7","key":"2592_CR65","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1089\/neu.2010.1724","volume":"28","author":"SN Zafar","year":"2011","unstructured":"Zafar SN, Iqbal A, Farez MF, Kamatkar S, de Moya MA. Intensive insulin therapy in brain injury: a meta-analysis. J Neurotrauma. 2011;28(7):1307\u201317. https:\/\/doi.org\/10.1089\/neu.2010.1724.","journal-title":"J Neurotrauma"},{"issue":"6","key":"2592_CR66","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1080\/02699052.2018.1457181","volume":"32","author":"RA N\u00fa\u00f1ez-Pati\u00f1o","year":"2018","unstructured":"N\u00fa\u00f1ez-Pati\u00f1o RA, Zorrilla-Vaca A, Rivera-Lara L. Comparison of intensive versus conventional insulin therapy in traumatic brain injury: a meta-analysis of randomized controlled trials. Brain Inj. 2018;32(6):693\u2013703. https:\/\/doi.org\/10.1080\/02699052.2018.1457181.","journal-title":"Brain Inj"},{"issue":"8","key":"2592_CR67","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0277-9536(98)00411-0","volume":"48","author":"GL Albrecht","year":"1999","unstructured":"Albrecht GL, Devlieger PJ. The disability paradox: high quality of life against all odds. Soc Sci Med. 1999;48(8):977\u201388. https:\/\/doi.org\/10.1016\/S0277-9536(98)00411-0.","journal-title":"Soc Sci Med"},{"issue":"4","key":"2592_CR68","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1097\/CCM.0000000000006174","volume":"52","author":"K Honarmand","year":"2024","unstructured":"Honarmand K, Sirimaturos M, Hirshberg EL, et al. Society of Critical Care Medicine Guidelines on glycemic control for critically ill children and adults 2024. Crit Care Med. 2024;52(4):e161\u201381. https:\/\/doi.org\/10.1097\/CCM.0000000000006174.","journal-title":"Crit Care Med"},{"key":"2592_CR69","doi-asserted-by":"publisher","unstructured":"Early worsening of diabetic retinopathy in the diabetes control and complications trial. Arch Ophthalmol. 1998;116(7):874. https:\/\/doi.org\/10.1001\/archopht.116.7.874","DOI":"10.1001\/archopht.116.7.874"},{"issue":"1","key":"2592_CR70","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12933-022-01686-3","volume":"21","author":"B Verg\u00e8s","year":"2022","unstructured":"Verg\u00e8s B, Aboyans V, Angoulvant D, et al. Protection against stroke with glucagon-like peptide-1 receptor agonists: a comprehensive review of potential mechanisms. Cardiovasc Diabetol. 2022;21(1):242. https:\/\/doi.org\/10.1186\/s12933-022-01686-3.","journal-title":"Cardiovasc Diabetol"}],"updated-by":[{"DOI":"10.1007\/s12028-026-02647-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000}}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-026-02592-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-026-02592-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-026-02592-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:01:46Z","timestamp":1791028906000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-026-02592-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":70,"alternative-id":["2592"],"URL":"https:\/\/doi.org\/10.1007\/s12028-026-02592-2","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised to replace Figures 2 and 3.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12028-026-02647-4","URL":"https:\/\/doi.org\/10.1007\/s12028-026-02647-4","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","label":"Conflicts of Interest","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The manuscript adheres to ethical clinical guidelines.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The protocol for this systematic review was published\n                      1\n                      and registered in the PROSPERO database with number CRD42023453612.","order":3,"name":"Ethics","label":"Clinical Trial Registration","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Microsoft Copilot was used solely for language editing and improvement of readability during manuscript preparation. The authors reviewed and edited all output and take full responsibility for the content of the manuscript.","order":4,"name":"Ethics","label":"Artificial Intelligence","group":{"name":"EthicsHeading","label":"Ethics"}}]}}